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Dicamba tolerant (DT) soybean, cotton and maize were developed through constitutive expression of
dicamba mono-oxygenase (DMO) in chloroplasts. DMO expressed in three DT crops exhibit 91.6e97.1%
amino acid sequence identity to wild type DMO. All DMO forms maintain the characteristics of Rieske
oxygenases that have a history of safe use. Additionally, they are all functionally similar in vivo since the
three DT crops are all tolerant to dicamba treatment. None of these DMO sequences were found to have
similarity to any known allergens or toxins. Herein, to further understand the safety of these DMO
variants, a weight of evidence approach was employed. Each puriﬁed DMO protein was found to be
completely deactivated in vitro by heating at temperatures 55 C and above, and all were completely
digested within 30 s or 5 min by pepsin and pancreatin, respectively. Mice orally dosed with each of
these DMO proteins showed no adverse effects as evidenced by analysis of body weight gain, food
consumption and clinical observations. Therefore, the weight of evidence from all these protein safety
studies support the conclusion that the various forms of DMO proteins introduced into DT soybean,
cotton and maize are safe for food and feed consumption, and the small amino acid sequence differences
outside the active site of DMO do not raise any additional safety concerns.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Weeds growing in planted ﬁelds represent one of the main
limiting factors to crop yields, since the weeds compete with the
crops for much-needed nutrients, sunlight and access to available
water resources (Gaddeyya and Ratna Kumar, 2014). The develop-
ment of herbicide tolerant crops has led to striking advancements
in weed management (Behrens et al., 2007; Cao et al., 2011). Crops
tolerant to herbicides, especially glyphosate, have been rapidly
adopted worldwide. Herbicide-tolerant adoption has been partic-
ularly rapid in soybeans, with U.S. farmers planting herbicide-
tolerant soybeans on 93% of all soybean acreage in 2013. Simi-
larly, herbicide-tolerant cotton occupied 82% of cotton acreage and
herbicide-tolerant maize 85% of maize acreage in U.S. in 2013
(Fernandez-Cornejo et al., 2014). While GM crops tolerant to her-
bicides such as glyphosate and glufosinate have proven valuable in
a commercial setting, crops tolerant to other herbicides are needed
to avoid over reliance on any single herbicide and to increaseang).
Inc. This is an open access article uoptions for managing difﬁcult to control weed species. Dicamba-
tolerant (DT) crops, including soybean, cotton and maize, have
been developed through the insertion of dicamba mono-oxygenase
(dmo) from Stenotrophomonas (formerly Pseudomonas) maltophilia.
The expressed DMO protein is targeted into chloroplasts with the
help of chloroplast transit peptides (CTP) for co-localization with
the endogenous NADH-dependent reductase and ferredoxin that
supply electrons for the DMO oxidative reaction (Chakraborty et al.,
2005; Herrmann, 1995; Klee et al., 1987). Plants producing DMO
protein are able to degrade dicamba, a broadleaf herbicide that has
been safely used for weed management in crops such as maize and
sorghum since the 1960s (EPA, 2006). Although dicamba has been
used for more than 50 years for the effective control of broadleaf
weeds in maize and other monocot crops, its application is limited
to speciﬁc development stages of these monocot crops and affected
by environmental factors (Cao et al., 2011). The availability of DT
crops, including maize, will provide farmers with additional
choices for effective weed management.
The guidance for assessing the safety of proteins introduced into
a GM crop has been developed and harmonized for more than 20
years (Delaney et al., 2008; Hammond et al., 2013; Herouet et al.,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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protein safety is founded on risk assessment principles that include
data from both hazard identiﬁcation studies and exposure assess-
ments. The Codex Alimentarius commission, which maintains
standards and codes of practice for international food trade, rec-
ommends that protein safety assessment include: (1) the evalua-
tion of the history of safe use of the donor organism and the protein
itself, (2) examination of whether the introduced protein has
structural similarity to known protein toxins, allergens and anti-
nutrients, (3) characterization of the physicochemical and func-
tional properties of the protein, (4) susceptibility to degradation by
gastrointestinal proteases, (5) evaluation of heat stability, and (6)
appropriate oral toxicity studies in cases where the introduced
protein is not similar to proteins that have previously been
consumed safely in food (Codex Alimentarius, 2009).
Plant and animal-derived proteins are routinely consumed as an
essential nutritional part of our diets and have a long history of safe
consumption. Each protein's unique sequence of amino acids es-
tablishes a-helices, b-strands, or other secondary structures that in
turn combine to form tertiary macromolecular shapes that confer a
speciﬁc function to the protein: structural, enzymatic, immuno-
logic, neuronal, or hormonal (Hammond and Jez, 2011). Collectively
a protein's sequence, structure and function can be used to group
proteins into evolutionarily related families (Hammond and Jez,
2011). Higher order structures are a relevant measure of homol-
ogy since structure is more conserved than amino acid sequence.
Changes in amino acid sequence are, evolutionarily, mostly con-
servative, meaning that the changes do not necessarily affect the
structure which also determines function (Caetano-Anolles et al.,
2009; Illergård et al., 2009). This conservation of structure is pre-
dominant within important functional and structural domains of
proteins in similar classes (Illergård et al., 2009). Therefore, it is
necessary to understand the different levels of protein structure to
properly assess homology and determine if homologs of a protein
of interest are widely distributed in nature or are present in sources
that have been consumed by humans and animals.
Rieske non-heme iron oxygenases are a family of proteins that,
while retaining well conserved secondary and tertiary structures
that confer similar enzymatic functionality, vary substantially at the
primary amino acid sequence level (Ferraro et al., 2005). One
member of the Rieske non-heme iron oxygenases, DMO, was
discovered to allow transgenic plants to degrade the popular her-
bicide dicamba, thereby enabling crops to be tolerant to this her-
bicide when DMO is expressed (Behrens et al., 2007; Cao et al.,
2011; Herman et al., 2005). The dmo gene was cloned from
S. maltophilia, strain DI-6 which was found at the site of a dicamba
manufacturing plant (Krueger et al., 1989). DMO is the terminal
Rieske oxygenase of a three component system that includes
ferredoxin and reductase. The crystal structure of DMO has been
solved (D'Ordine et al., 2009; Dumitru et al., 2009) and demon-
strated that the DMO monomer contains a Rieske [2Fe-2S] cluster
domain and a non-heme iron center, a structure that is conserved
across many Rieske-type monooxygenases. Functional DMO is a
homotrimer with an arrangement of neighboring inter-subunit
Rieske domains and non-heme iron sites similar to other struc-
turally characterized Rieske oxygenases, and this arrangement of
neighboring inter-subunit enables electron transport.
Previously conducted searches of publicly available databases
using the DMO amino acid sequence from S. maltophilia DI-6 as a
query yielded homologous proteins from many different species
with amino acid sequence identity ranging up to as much as 42%
(D'Ordine et al., 2009). Rieske non-heme iron oxygenases are
ubiquitous in bacteria and plant species (Darrouzet et al., 2004;
Ferraro et al., 2005; Gray et al., 2004; Hibino et al., 2002). No
food safety concern has been reported to be associated with Rieskenon-heme oxygenases and functionally conserved proteins from
this superfamily are widely present in plants that have a history of
safe consumption.
DMO expressed in three DT crops (soybean, cotton, maize)
exhibit 91.6e97.1% amino acid sequence identity to wild type DMO
due to differential processing of CTP in the various plant species
and different vector cloning processes during development of each
DT crop. In the present report we describe the results from studies
assessing the safety of the speciﬁc forms of DMO expressed in three
different DT crops using the Codex weight of evidence approach.
Speciﬁcally, the goal is to see whether the safety assessment results
are affected by having up to 8.4% amino acid sequence differences
across these three forms of DMO, or are consistent with the shared
structural and functional similarities of these proteins.
2. Materials and methods
2.1. Development of DT crops
DT cotton and DT maize were developed by expressing the dmo
gene from S. maltophilia (hereafter called “wild-type DMO”) fused
with a CTP from Arabidopsis 5-enolpyruvylshikimate-3-phosphate
synthase (EPSPS) and a CTP from petunia hybrid EPSPS (Feng and
Brinker, 2014), respectively. A leucine codon was added at posi-
tion 2 of wild type dmo to aid the cloning process during plant
vector construction (Feng and Brinker, 2014). DT soybean was
developed in a similar way, but with three differences (Behrens
et al., 2007): 1) the CTP was from pea (Pisum sativum) Rubisco
small subunit, 2) the N-terminal 27 amino acids from the coding
region of the pea Rubisco small subunit/intervening sequence was
located between the CTP and the amino terminus of the coding
region of dmo to potentially stabilize expression of this protein in
planta, and 3) an alanine codon was introduced at position 2 to
facilitate vector cloning and a cysteine replaced tryptophan at po-
sition 112 compared to wild type DMO. Fig. 1 illustrates the various
forms of DMO present in the transformed crops, in which the DMO
in DT soybean, DTcotton and DTmaize are designated sDMO, cDMO
and mDMO, respectively.
2.2. Production of DMO proteins
The DT soybean-produced DMO was puriﬁed from DT soybean
grain involving a multi-step process including extraction, diaﬁl-
tration, hydrophobic chromatography, anion exchange chroma-
tography, concanavalin A-based chromatography, and ceramic
hydroxyapatite chromatography. About 70 mg of sDMO was
obtained.
The coding sequence corresponding to cDMO was cloned into a
pET20 vector (Novagen, Madison, WI) and expressed in BL21 (DE3)
E. coli (Invitrogen, Carlsbad, CA). The procedure to isolate cDMO
from E. coli cells involves a multi-step process including ammo-
nium sulfate precipitation, hydrophobic interaction chromatog-
raphy, anion exchange chromatography and ceramic
hydroxyapatite chromatography. Using the same protocol, a small
amount of cDMOwas also puriﬁed fromDTcotton grain to assess its
equivalence to the E. coli-produced protein.
The coding sequence corresponding to mDMO (DMOþ12, the
longer one, Fig. 1B) was cloned into a pET19 vector (Novagen,
Madison, WI) and expressed in BL21 (DE3) star E. coli (Invitrogen,
Carlsbad, CA). The procedure for mDMO production in E. coli was
the same as for cDMO, except that the ammonium sulfate precip-
itation was omitted. A small amount of the plant-produced mDMO
protein was puriﬁed from DT maize grain to assess its equivalence
to the E. coli-produced protein. The mDMO was isolated from DT
maize grain using the DMO speciﬁc monoclonal antibody-based
Fig. 1. Various forms of DMO. A: Western analyses of DMO expressed in various DT
crops. Grain extracts were separated on Tris-glycine 4e20% polyacrylamide gels under
denaturing and reducing conditions and transferred to nitrocellulose membranes.
Blots were probed with goat anti-DMO speciﬁc polyclonal antibodies and developed
using an enhanced chemiluminescence system. A: soybean grain extract, B: cotton
seed extract, C: maize grain extract; 1: conventional crops, 2: DT crops. B: Amino acid
sequence comparison of DT crop-produced DMO. The wild type dmo coding region
introduced into soybean, cotton and maize to confer the identical function of dicamba
tolerance to their respective GM crop (DT soybean, DT cotton, DT maize) is the dmo
gene cloned from S. maltophilia (Herman et al., 2005). The number and amino acid
residues listed at N-terminus indicate extra amino acids added to the DMO coding
sequence. Arrows refer the positions with different amino acid. The DMO in DT soy-
bean (sDMO) has three differences: 1) in approximately 60% of the expressed DMO, it
includes 27 additional amino acids (*MQVWPPIGKKKFETLSYLPPLTRDSRA) from the N-
terminal coding region of the pea Rubisco small subunit and an intervening sequence
at the N-terminus, 2) an additional alanine in position 2 for cloning purpose, and 3) a
cysteine instead of tryptophan at position 112. In DT cotton, the introduced DMO
(cDMO) includes: 1) nine extra CTP-derived N-terminal amino acids and 2) an addi-
tional leucine in position 2 added for cloning purpose. For DT maize, the introduced
DMO (mDMO) includes: 1) a mixture of 7 and 12 extra CTP-derived N-terminal amino
acids and 2) the additional leucine in position 2 like in cDMO. sDMO, cDMO and
mDMO sequences were reported previously (Behrens et al., 2007; Feng and Brinker,
2014).
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type DMO protein.2.3. Characterization of DMO proteins
All methods used to characterize proteins that are introduced
into GM crops have previously been reported (Wang et al., 2015)
andwere similarly used to characterize sDMO, cDMO andmDMO in
this study. The concentration of total proteinwas determined using
quantitative amino acid compositional analysis. Purity and
apparent molecular weight of the various DMO proteins were
determined using densitometric analysis of stained SDSePAGE gels.
For immunoblot analysis, each DMO protein was subjected to
SDSePAGE and transferred to a nitrocellulose membrane. The blot
was probed with a goat anti-DMO speciﬁc polyclonal antibody
raised against the E. coli-expressed wild type DMO protein. Glyco-
sylation analysis was conducted following ECL GlycoproteinDetection method (GE Healthcare, Piscataway, NJ) and transferrin
was used as a positive control. Matrix-assisted laser desorption/
ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS) was
used to conﬁrm the identity of each DMO form by tryptic digest
mapping (Wang et al., 2015). N-terminal sequence analysis was
performed for 15 cycles using an Applied Biosystems 494 Procise
Sequencing System (Hunkapiller and Hood, 1983; Wang et al.,
2015). DMO activity assay was performed according to the
method reported previously (D'Ordine et al., 2009). The equiva-
lence between plant- and E. coli-produced proteins was evaluated
using approaches described previously (Wang et al., 2015).
2.4. Bioinformatic assessment of potential DMO allergenicity and
toxicity, and assessment of DMO susceptibility to pepsin and
pancreatin
Bioinformatic assessments of potential allergenicity, toxicity
and antinutrients, were derived from those described previously by
Wang et al. (2015), the exceptions being that 2016 versions of da-
tabases were used and the full 35% over 80 amino acid threshold
search was able to be conducted (Codex Alimentarius, 2009). The
all protein database used was GenBank release 209, the updated
toxin database (TOX_2016) contains 18,554 sequences, and the
allergen database (AD_2016) contains 1956 (FARRP, 2016). A BLAST
(v 2.2.32þ) search of the non redundant protein database from
GenBank release 211 using DMO as a query was conducted
(Altschul et al., 1997). FASTA (v36.3.5e) was used to conduct all pair
wise comparisons (Pearson, 2000). Assessment of protein suscep-
tibility to pepsin and pancreatin were conducted as described
previously (Wang et al., 2015).
2.5. Heat stability study
Puriﬁed DMO protein was placed in the appropriate heat
treatments at 25, 37, 55, 75, or 95 C ± 2 and incubated for 15 min,
respectively. All samples were returned to wet ice immediately
following the heat treatments. The control sample was maintained
on wet ice throughout the treatment period. Following the heat
treatments, all samples were subjected to functional activity anal-
ysis (D'Ordine et al., 2009).
2.6. Acute oral toxicity assessment
Separate acute oral toxicity studies were conducted in CD-1
mice with each DMO form. The study designs were adapted from
the EPA OPPTS Guideline 870.1100, were compliant with Good
Laboratory Practices (GLPs), and were conducted at Charles River
Laboratories, Spencerville, OH (an Association for Assessment and
Accreditation of Laboratory Animal Care accredited facility). The
sDMO dose formulationwas prepared with a vehicle buffer (20 mM
potassium phosphate, pH 8.0) at a dose concentration of 4.2 mg/ml
for targeting 140 mg sDMO/kg body weight, and the cDMO and
mDMO dose formulations were prepared in the same vehicle buffer
at dose concentrations of 8.5 mg/ml and 33.7 mg/ml for targeting
283 and 1000 mg/kg body weight, respectively. The dosing for-
mulations were analyzed to conﬁrm concentration, homogeneity,
and stability. Brieﬂy, mice were dosed once by oral gavage with a
dose volume of 33.3 ml/kg on Day 0 and observed for 14 days
thereafter (Wang et al., 2015). Five male mice (Day 0 fasted body
weight range 29.2e31.7 g) and 5 female mice (Day 0 fasted body
weight range 23.4e27.7 g) were administered sDMOwhile 10 male
and 10 female mice were administered cDMO (males, Day 0 fasted
body weight range 25.7e31.5 g; females, Day 0 fasted body weight
range 20.5e25.3 g) or mDMO (males, Day 0 fasted body weight
range 28.9e33.5 g; females, Day 0 fasted body weight range
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and observation periods included: survival, clinical observations,
body weights, body weight changes, and food consumption.
Following the observation period, all surviving animals were hu-
manely euthanized and subjected to a necropsy. The necropsy
included macroscopic examination of the carcass and musculo-
skeletal system; all external surfaces and oriﬁces; cranial cavity and
external surfaces of the brain; and thoracic, abdominal, and pelvic
cavities with their associated organs and tissues under the super-
vision of a board-certiﬁed veterinary pathologist.
Body weight, body weight change, and food consumption data
were statistically analyzed. Each data set was analyzed for homo-
geneity of variance (e.g., Levene's test). If the homogeneity of
variance analysis was not signiﬁcant, a single-factor parametric
ANOVA was applied (p < 0.05) and Dunnett's test was used to
identify statistically signiﬁcant differences between the control
group and the test substance-treated group (p < 0.05). If the ho-
mogeneity of variance analysis was signiﬁcant, a Kruskal-Wallis
non-parametric ANOVA was applied (p < 0.05) and Dunn's test
was used to identify statistically signiﬁcant differences between the
control group and the test substance-treated group (p < 0.05).
2.7. Sequence alignment and structure homology analyses
To compile a protein dataset to compare with the wild type
DMO from S. maltophilia (GI-55584974), the Rieske superfamily
(Accession: cl00938) in NCBI's Conserved Domain Database (CDD)
(Marchler-Bauer et al., 2015) was searched for members of known
protein sequence or structure, with plant derived sequences being
preferentially selected when possible. Using these criteria, 17 se-
quences were selected from the Rieske non-heme iron oxygenase
family (the subfamily of the Rieske superfamily which contains
DMO), and an 18th sequence (GI-402715431 from Sulfolobus acid-
ocaldarius) was selected on the basis of having a known structure
and belonging to a separate, but related subfamily, in order to serve
as an out-of-group protein.
Amino acid alignments were generated with MUSCLE v3.8.31
(Edgar, 2004) and manually masked using Seaview v4.5.3 to ulti-
mately retain 276 positions for tree-building. ProtTest v 3.4 (Darriba
et al., 2011) was used to select WAG þ I þ G as the best-ﬁt model of
amino acid replacement with both Akaike and Baysian information
criterion (AIC and BIC). The maximum likelihood tree was built
using RAxML v8.1.3 (Stamatakis, 2014) under the calculated best ﬁt
model with 10,000 rapid bootstrap replicates. Final trees were
drawn in FigTree v1.4.2 (Rambaut, 2012) and color coded to
correspond to colors of contained members with a known protein
structure. In the event a region of the tree did not have a publically
available structure, the area was colored grey. Structural models
were visualized and generated with Cn3D viewer v4.3 (Wang et al.,
2000) and analogously colored to correspond to their respective
regions of the phylogenetic tree (Fig. 2).
2.8. Dicamba tolerance injury ratings
DT crops and their respective isogenic conventional controls
were grown in a greenhouse. There were 10 replicate pots with one
plant in each pot of DT crop and the conventional control for each
tested rate of dicamba application. The pots were randomly placed
in a greenhouse. Two different application rates were applied to
different replicate sets (see Table 2). Based on the U.S. herbicide
labeled rates, the rates for the experiments were chosen and then
adjusted for use on crops and for the optimal growing conditions in
the greenhouse in order to achieve moderate to severe injury of
non-DT plants. All plants were rated for percent injury. Ratings
were based on visual assessment of chlorosis, necrosis,malformation, stunting, and biomass reduction with 0 being no
visible injury to 100 percent, completely dead. All 10 replicate
ratings were averaged.
At the V2-V3 growth stage, soybean plants were sprayed with
dicamba. Twenty to 21 days after application, all plants were rated
for percent injury. At the 2e5 leaf growth stage, cotton plants were
sprayed with dicamba. Twenty to 22 days after application, all
plants were rated for percent injury. At the 2 to 3 leaf growth stage,
maize plants were sprayed with dicamba. Fifteen days after her-
bicide application, all plants were rated for percent injury. The di-
camba treatment rate used in the study is summarized in Table 2.
3. Results
3.1. Assessing the bioinformatic relationship of DMO to proteins in
database
To evaluate the similarity of DMO to known proteins, a BLAST
search of the non-redundant protein database from GenBank
release 211 using wild type DMO as a query was conducted. This
bioinformatic search resulted in several notable hits beyond the
self-identiﬁcation of DMO, one protein from Sphingobium fuliginis
(AJS19061.1) with 99% amino acid sequence identity to DMO, a
hypothetical protein from Sphingomonas sp. Y57
(WP_047168602.1) with 97% sequence identity to DMO, a hypo-
thetical protein from Sphingomonas sp. SRS2 (KKC23919.1) which
displayed 58% sequence identity to DMO, and a hypothetical pro-
tein from Herbaspirillium autotrophicum (WP_050460939.1) dis-
playing 45% identity to DMO. Notably, each of these sequences
exceeds the similarity of the closest recognized sequences which
had been described previously at ~42% identity (D'Ordine et al.,
2009), indicating that DMO homologs appear to be more abun-
dant than originally reported.
For the sequence and structure homology comparison, eighteen
protein sequences were selected from the Rieske superfamily on
the basis of being proteins from bacteria or plants with solved
structures and/or being closely related to proteins with known
structures (Table 1). FASTA was used to conduct a pair-wise com-
parison between each of the 18 selected proteins with thewild type
DMO and displays identities ranging from 24 to 41% and similarities
ranging from 46% to 69% (Table 1).
The bacterial proteins naphthalene 1,2-dioxygenase, biphenyl
2,3-dioxygenase, and the oxygenase of 3-ketosteroid 9-alpha-hy-
droxylase all possess a similar three dimensional structure to the
DMO protein (Fig. 2), although their amino acid sequences share
less than 27% identity with DMO (Table 1). While three dimensional
structures are not publically available for known Rieske proteins
from food plants, the conserved regions of their structures can be
estimated by superimposing their amino acid sequence to a
neighboring known structure. These sequence and structure ana-
lyses showed that the DMO in DTcrops is highly structurally similar
to oxygenases present in crops with a history of safe consumption,
such as sugar beet (Betula vulgaris), maize (Zea mays), tomato (So-
lanum lycopersicum) and rice (Oryza sativa) (Fig. 2). Evolutionarily
the DMO protein appears to be structurally related to proteins that
are involved in essential plant biochemical pathways such as
chlorophyll and vanillate metabolism (Fig. 2), both of which are
ubiquitous in the diet.
3.2. DMO expression and identity in DT crops
Transgenic soybean, cotton and maize expressing dmo each
demonstrated dicamba resistance when dicamba was applied as
compared to the respective conventional control (Table 2).
Western blotting results showed that DT soybean contains a
Fig. 2. DMO phylogenetic tree and structure similarity analyses. A maximum likelihood phylogeny of members of the Rieske non-heme iron oxygenase family anchored by the
Rieske iron-sulfur protein II from Sulfolobus acidocaldarius. Numbers at nodes represent maximum likelihood support. Colored regions of the tree designate common protein
function and correspond to the protein structure of the same color. Grey regions represent proteins which do not have explicitly known structures. For these regions without a
known structure, a member's amino acid sequence was overlaid on a known neighboring structure and designated with an asterix (*). These overlaid ﬁgures display regions of 100%
identity in red and semi-conserved “block” regions in blue and have had their features colored grey. The numbers correspond to the numbers and descriptions provided in Table 1.
Table 1
Amino acid sequence identity and similarity between DMO and other proteins present in bacteria and plants.
Number GI Name Protein Identity Similarity
1 402715431 Sulfolobus acidocaldarius Rieske iron-sulfur protein II 25.70% 46.90%
2 20137680 Betula vulgaris choline monooxygenase 26.20% 53.40%
3* 33300598 Oryza sativa Japonica Group choline monooxygenase 24.20% 51.70%
4 37622229 Mycobacterium sp. JLS Naphthalene 1,2-Dioxygenase 28.20% 54.10%
5 78101551 Rhodococcus Sp. Naphthalene 1,2-Dioxygenase 25.70% 51.80%
6 1354284 Cycloclasticus oligotrophus Biphenyl 2,3-dioxygenase 26.90% 51.30%
7 3023401 Pseudomonas sp. Biphenyl 2,3-dioxygenase 25.20% 51.60%
8 57116474 Comamonas testosteroni Isovanillate oxygenase 35.10% 60.60%
9 357938873 Burkholderia sp. YI23 vanillate monooxygenase** 41.00% 69.00%
10 55584974 Stenotrophomonas maltophilia dicamba O-demethylase 100.00% 100.00%
11 766695610 Sphingobium fuliginis dicamba O-demethylase** 99.70% 99.70%
12* 1935909 Zea mays pheophorbide A oxygenase 34.70% 60.20%
13 30088964 Vigna unguiculata pheophorbide A oxygenase 31.10% 51.90%
14 16973465 Solanum lycopersicum pheophorbide A oxygenase 32.40% 58.00%
15 15230543 Arabidopsis thaliana pheophorbide A oxygenase 33.50% 58.00%
16 21309823 Rhodococcus erythropolis oxygenase of 3-ketosteroid 9-alpha-hydroxylase 26.30% 55.00%
17 89243566 Mycobacterium smegmatis oxygenase of 3-ketosteroid 9-alpha-hydroxylase 25.30% 56.00%
18* 5669528 Burkholderia pyrrocinia aminopyrrolnitrin oxygenase 29.40% 55.30%
19 68345267 Pseudomonas protegens Pf-5 aminopyrrolnitrin oxygenase 30.30% 53.70%
Underlined numbers indicate that a corresponding structure or overlaid structure is given in the ﬁgure. Figures corresponding to numbers designated with an asterix (*) are of
a neighboring structure overlaid with the given proteins amino acid sequence. In the case of overlaid ﬁgures, identities are shown as red and conserved blocks as blue. Percent
identity and similarity were calculated using FASTA v36.3 to align the given protein against the DMO (GI-55584974) and retaining the most optimum alignment. **the
sequence showed up in top 500 alignments of the original blast search.
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weights of ~42.0 and 39.8 kDa (Fig 1A_A). To further charac-
terize these two forms of DMO protein, the DMO was partially
puriﬁed through immunoprecipitation and SDS-PAGE. Edman
sequencing and MALDI-TOF-MS analyses of the partially puri-
ﬁed DMO sample conﬁrmed that the 39.8 kDa peptide corre-
sponds to the mature DMO protein with the N-terminal
methionine cleaved, which is common in many organisms
(Bradshaw et al., 1998), whereas the 42.0 kDa form is DMO plus
27 amino acids originating from the pea Rubisco small subunit
and intervening sequence on its N-terminus starting with resi-
dues MQVWPPIGKKKFETL.
Similarly to DT soybean, two forms of DMO from DT maize weredetected by Edman sequencing and mass spectrometry analyses.
Based on results of N-terminal sequence analyses, the smaller form
has 7 extra amino acids on its N-terminus starting with residues
ASVATAC and the larger form has 12 additional amino acids on its
N-terminus starting with residues SFRISASVATAC compared to the
wild type DMO (Fig. 1B). The two forms are indistinguishable by
SDS-PAGE due to the small mass difference (Fig. 1A_C). These extra
amino acids originate from the CTP of petunia hybrid EPSPS (Fig.1B).
In contrast to DT soybean and maize, Edman sequencing and
mass spectrometry analyses conﬁrmed that DT cotton produced
only one form (Fig. 1A_B) that has 9 extra amino acids originating
from the CTP of Arabidopsis EPSPS on its N-terminus starting with
residues VMSSVSTAC. DMO expressed in these three DT crops
Table 2
Dicamba tolerance injury ratings.
Crops Labeled rate range (g/ha)a Rates applied (g/ha)a Injury ratings (%)b




















a Crops were sprayed with Clarity® produced by BASF. Clarity® contains the salt form of dicamba. When determining the rate of application, the salt form is calculated back
to the acid that is the active ingredient.
b Ratings were based on visual assessment of chlorosis, necrosis, malformation, stunting, and biomass reduction with 0 being no visible injury to 100 percent, completely
dead. All 10 replicate ratings were averaged.
Fig. 3. SDS-PAGE analyses of puriﬁed DMO proteins. DMO protein samples were
subjected to pre-cast Tris-glycine 4e20% (w/v) SDS-PAGE and stained with Brilliant
Blue G-Colloidal stain. Approximate MWs (kDa) are shown on the left. Lane 1: 0.5 mg
soybean seed-produced sDMO, lane 2: 0.5 mg E. coli-produced cDMO, lane 3: 0.5 mg
cotton seed-produced cDMO, lane 4: E. coli-produced 1 mg mDMO, lane 5: 0.5 mg maize
grain-produced mDMO.
Fig. 4. Western blot analysis of DT crop and E. coli-produced DMO proteins. DMO
protein samples were subjected to SDS-PAGE and electrotransferred to PVDF mem-
brane (A, D and E) and nitrocellulose membrane (B and C). Proteins were detected
using an anti-DMO speciﬁc polyclonal antibody. Immunoreactive bands were visual-
ized using HRP-conjugated secondary antibodies and an ECL system. A: sDMO, 20 ng;
B: the E. coli-produced cDMO, 0.5 ng; C: the DT cotton-produced cDMO, 0.5 ng; D: the
E. coli-produced mDMO, 1 ng; E: the DT maize-produced mDMO, 1 ng.
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(Fig. 1B).
3.3. Puriﬁcation and characterization of DMO proteins
DMO expression levels estimated by ELISA are 43, 20 and
0.19 ppm in grains of DT soybean, DT cotton and DT maize,
respectively. To obtain DMO proteins from each DT crop for safety
assessment, two different approaches were needed. sDMO, with a
purity of 81%, was isolated directly from DT soybean seed to ensure
that the natural ratio of the two different forms of DMO observed in
DT soybean was retained and reﬂected in the safety assessment
(Fig. 3A).
It is difﬁcult to isolate sufﬁcient quantities of cDMO and mDMO
directly from plant tissues for safety assessment. Therefore, heter-
ologous expression of these DMO proteins in E. coli was used for
their production. For cotton, the DMO with additional 9 amino
acids derived from CTP was expressed in E. coli and isolated with a
purity of 88% (Fig. 3B). The DMO in DT maize is a mixture of two
forms. Since the smaller form of mDMO (7 CTP-derived N-terminal
amino acids) is encompassed in the larger form (12 CTP-derived N-
terminal amino acids), the safety assessment of this larger form
would cover the smaller one. Therefore, the longer form of mDMOwas expressed and isolated from E. coliwith a purity of 97% (Fig. 1B;
Fig. 3C).
To demonstrate that heterologously expressed cDMO and
mDMO are equivalent to the DMO proteins in DT cotton and DT
maize, respectively, a small amount of DMO proteins were puriﬁed
directly from their respective DT crops (Fig. 3). The apparent mo-
lecular weights of plant- and E. coli-produced cDMO, and plant- and
E. coli-produced mDMO were similar, respectively, as assessed on
SDS-PAGE gels (Fig. 3B and C). All puriﬁed DMO proteins were
immunoreactive with the antibodies prepared with the wild type
DMO (Fig. 4). Immunoreactivities of DT crop-produced cDMO and
mDMOwere comparable to that of their respective E. coli-produced
DMO (Fig. 4, B and C; D and E). No glycosylation was detected for
puriﬁed DMO proteins from any of the DT crops or E. coli (data not
shown).
As shown in Table 2, all three DT crops exhibited reduced injury
ratings by dicamba when compared to their respective conven-
tional control, indicating that the expression of each of the
respective forms of DMO inactivated dicamba. Similarly, the puri-
ﬁed respective forms of DMO from the three DT crops and E. coli
were shown to be active in vitro. Although batch to batch
Fig. 5. DMO degradation by pepsin. A: SDS PAGE analysis of sDMO protein degra-
dation by pepsin. sDMO proteins were resolved by a pre-cast tricine 10e20% (w/v)
polyacrylamide gradient mini-gels and tricine-SDS running buffer (Invitrogen, Carls-
bad, CA), and stained by Colloidal Brilliant Blue G. One mg of sDMO proteins were
loaded in each lane containing DMO protein. The incubation times are indicated. Lanes
1 &14: molecular weight markers, lanes 2 & 13: pepsin only, lanes 3 & 12: sDMO only,
lanes 4 to 11: a time course of pepsin digestion. B: Western blot analysis of sDMO
protein degradation by pepsin. sDMO proteins were resolved by a pre-cast tricine
10e20% polyacrylamide gradient mini-gel and electrotransferred onto a nitrocellulose
membrane. The blot was probed with an anti-DMO speciﬁc polyclonal antibody and
developed using an enhanced chemiluminescence system. Twenty ng of sDMO pro-
teins were loaded in each lane containing DMO protein. The incubation times are
indicated in the Fig. Lanes 1 &12: pepsin only, lanes 2 & 11: sDMO only, lanes 3 to 10: a
time course of pepsin digestion. Lane 13: molecular weight markers.
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components in the DMO activity assay signiﬁcantly affect the
overall reaction process (Herman et al., 2005), it is noteworthy that
the speciﬁc activity for sDMO, cDMO andmDMOwere similar at 62,
43 and 114 nmol DCSA/min/mg, respectively. Therefore, all prepa-
rations of DMO used for the various studies used for weight of
evidence assessment of the overall safety of the DMO protein forms
from these three DT crops were conﬁrmed to be positive for DMO
activity. These glycosylation, immunoreactivity, functional activity
and apparent molecular weight analyses support that the E. coli-
produced DMO were suitable surrogates for assessing the safety of
plant-produced DMO fromDTcotton and DTmaize (Raybould et al.,
2013; Wang et al., 2015), respectively.
3.4. Bioinformatics analyses of potential allergenicity and toxicity of
DMO in DT crops
A key element of the safety evaluation for introduced proteins in
GM crops is a bioinformatic analysis to assess whether the intro-
duced protein shows similarity to known toxins or allergens
(Hammond et al., 2013; Kier and Petrick, 2008). Bioinformatics
analyses were performed on the translated sequence of the DMO
coding sequence in these three DT crops to assess their structural
relatedness with known allergens and toxins. The results of the
search comparisons showed that no relevant alignments were
observed against proteins in the allergen database (FARRP, 2016)
Likewise, no relevant alignment was observed with the translated
open reading frame derived from the various DMO genes in these
three DTcrops compared to proteins in a database of knownprotein
toxins. These data demonstrate the lack of sequence similarities
between the various forms of DMO sequences from these three DT
crops to any known allergenic or toxic proteins and that the small
differences in sequence have no impact on this bioinformatic
assessment.
3.5. Assessment of DMO susceptibility to digestive enzymes
Most dietary proteins are rapidly degraded by digestive pro-
teases to aid absorption of nutritional amino acids, and as a result,
minimizing exposure to intact proteins following consumption
(Hammond et al., 2013; Kier and Petrick, 2008). Assessing suscep-
tibility of a protein in a GM crop to proteolytic degradation,
therefore, is a key study in the overall weight of evidence analysis of
the safety of a protein (Codex Alimentarius, 2009). The DMO pro-
teins in all three DT crops were assessed for their susceptibility to
pepsin using a standardized assay (Thomas et al., 2004). Studies
with sDMO are shown as representative for this group of DMO
proteins.
Cleavage of sDMO proteins by pepsin was evaluated by visual
analysis of a stained polyacrylamide gel (Fig. 5A). The apparent
molecular weights of pepsin (~38 kDa) and the mature form of
sDMOwith no CTP amino acids (~39 kDa) are similar (Fig. 5A, lanes
2 and 3, respectively); therefore, it is difﬁcult to distinguish be-
tween the two on an SDS-PAGE gel (a situation that is similar for
most other DMO forms). However, the intensity of the combined
band at pepsin treated 0min (lane 4) appears to be the combination
of the intensity of both proteins run separately, which was further
conﬁrmed by running an 8% gel system that clearly separated both
forms but did not allow for the observation of lower molecular
weight bands, if present (results not shown). Visual examination of
a stained gel showed that full-length sDMO proteins were rapidly
degraded below the limit of detection (LOD) within 0.5 min of
exposure to pepsin. On the stained gel, a transiently stable frag-
ment with a molecular weight of ~21 kDa was observed (Fig. 5A,
lanes 3 & 4), but it was not recognized by a western analysis(Fig. 5B). N-terminal sequencing (not shown) identiﬁed only 4
consecutive amino acid residues due to limited amount of the
fragment, which did not match sDMO protein sequences. Most
likely, the fragment originated from an endogenous soybean pro-
tein co-puriﬁed with sDMO. Such a fragment was not detected
during pepsin digestion of cDMO or mDMO.
Pepsin treated sDMO protein samples were also analyzed by
western blot analysis (Fig. 5B). The western blot used to assess the
resistance of sDMO proteins to pepsin degradation (Fig. 5B) was run
concurrently with a western blot to estimate LOD of sDMO proteins
(not shown). The LOD was used to calculate the maximum relative
amount of sDMO protein that could remain visually detectable after
digestion, which is approximately 1.5% of the initial amount protein
loaded. Therefore, based on the LOD, at least 98.5% of sDMO
Fig. 6. Western blot analysis of DMO protein degradation by pancreatin. Western blot
probed with an anti-DMO speciﬁc polyclonal antibody was used to assess the degra-
dation of sDMO proteins by pancreatin. Molecular weights (kDa) are shown on the left
of the image. Twenty ng of sDMO proteins were loaded in each lane containing DMO
protein. sDMO proteins were resolved by a pre-cast tricine 10e20% polyacrylamide
gradient mini-gel and electrotransferred onto a nitrocellulose membrane. The blot was
probed with an anti-DMO speciﬁc polyclonal antibody and developed using an
enhanced chemiluminescence system. The incubation times are indicated. Lane 1:
molecular weight markers, Lanes 2 & 14: pancreatin only, lanes 3 & 13: sDMO only,
lanes 4 to 12: a time course of pepsin digestion.
Fig. 7. Heat stability of various forms of DMO. Puriﬁed DMO proteins were heated over
a temperature range of 25e95 C for 15 min and then subjected to functional activity
analysis. Mean speciﬁc activity was determined from n ¼ 3. The DMO activity of non
heat treated samples was assigned 100% active. Relative activity ¼ [speciﬁc activity of
heat treated sample/speciﬁc activity of non heat treatment sample] x 100.
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To better understand the digestive fate of DMO protein, an
assessment of the susceptibility of sDMO to pancreatin at neutral
pH was also conducted. Due to the many proteins from the
pancreatin preparation that would be visualized on a stained SDS-
PAGE, the susceptibility of sDMO to pancreatin degradation was
evaluated by western blot analysis (Fig. 6). Visual examination of
the western blot demonstrated that DMO was degraded by
pancreatin within 5 min, the ﬁrst time point assessed with no
visible fragments (Fig. 6, lane 5). These results demonstrated that
sDMO proteins are readily susceptible to degradation by digestive
enzymes. cDMO andmDMOwere also found to be rapidly degraded
by digestive enzymes, similar to the results shown in Figs. 5 and 6
for sDMO (data not shown). Again, the differences in sequence
among the three DMOs did not result in any differences in their
susceptibility to these digestive enzymes.
3.6. Thermal stability of DMO protein
The thermal stability of DMO was evaluated by determining the
percent residual enzyme activity following heat treatment
compared with the activity of untreated DMO protein. The enzy-
matic activity of all forms of DMO was stable at incubation tem-
peratures up to 37 C, which is comparable to previous reports
(Chakraborty et al., 2005; Herman et al., 2005). However, enzy-
matic activities of all forms of DMO were not detected following
incubation at temperatures equal or above 55 C (Fig. 7), indicating
that they were all equally heat labile.
3.7. Assessment of potential oral toxicity of DMO
The assessment of protein safety is largely based on the “weight
of evidence” studies already presented (e.g., history of safe use,
bioinformatic comparison of amino acid sequence to known aller-
gens, protein toxins and antinutrients, stability to heat or pro-
cessing and susceptibility to degradation by pepsin), and is in large
part consistent with the tiered testing strategy advocated by the
International Life Science Institue's International Food Biotech-
nology Committee Task Force on Protein Safety (Delaney et al.,2008). Other international food safety organizations indicate that
if a history of safe use is apparent and weight of evidence results
suggest no concern regarding safety, oral toxicity studies should not
be necessary (Codex Alimentarius, 2009). Despite these recom-
mendations, a precautionary approach leading to oral toxicity
studies of proteins incorporated into crops has become a part of
safety assessment. Although DMO is homologous to proteins
expressed in many plants commonly consumed as food and feed;
and the weight of evidence from the safety studies with the sDMO,
cDMO, and mDMO proteins support a conclusion that these pro-
teins are safe, acute toxicity studies in mice were also conducted in
an additional attempt at hazard identiﬁcation. The experimental
design for each of the studies conducted with sDMO, cDMO or
mDMO was similar in that the test group of animals (male and
female) received their doses by oral gavage and a concurrent con-
trol group received a similar dose level of bovine serum albumin to
control for potential formulation effects (i.e., the administration of a
relatively large volume of a concentrated protein solution could
induce satiety and reduce food consumption) and thereby better
distinguish test substance-related effects. As summarized in
Table 3, the test groups of mice were dosed at 140, 283 or 1000 mg
DMO/kg body weight for sDMO, cDMO or mDMO, respectively.
Following the day of dosing, the animals were observed for 14 days,
humanely euthanized, and subsequently subjected to a macro-
scopic examination of their gross anatomy. At completion of the 14
days of observations, no mortality occurred and there were no
adverse test substance-related clinical ﬁndings observed following
treatment with sDMO, cDMO andmDMO. Occasional ﬁndings were
noted during the clinical observations (stained fur, unkempt
appearance, etc.); but these ﬁndings did not correlate with signs of
toxicity, are common clinical ﬁndings in the CD-1 mouse (e.g.,
unkempt appearance), occurred at a similar rate in concurrent
control, and/or were of an isolated and transient nature. Conse-
quently, they were determined to be unrelated to treatment. There
were no adverse test substance-related effects of sDMO, cDMO or
mDMO on body weight, body weight change, or food consumption.
Occasional statistically signiﬁcant differences were noted in these
endpoints, but the differences were determined to be spurious
because the difference was detected in a single gender, the direc-
tion of the change was not commonly associated with toxicity (e.g,
higher weight gain at one study interval), and/or were within the
Table 3
Summary of acute toxicity study results for various forms of DMO.





Day 0e7, 7e14 (grams/Animal/Day)
Macroscopic observations
at necropsy (test)
Test Control Test Control Test Control
sDMO (140)
Male 33.2 [þ2.2]a 32.5 2.6 [þ23.8] 2.1 6.4 [3.0], 6.8 [2.9] 6.6, 7.0 NTFb
Female 28.1 [0.7] 28.3 2.5 [19.4] 3.1 6.5 [þ6.6], 7.0 [þ7.7] 6.1, 6.5
cDMO (283)
Male 35.0 [þ0.9] 34.7 6.0 [þ5.3] 5.7 7.3 [11.0], 7.1 [10.1] 8.2, 7.9 NTF
Female 26.9 [þ1.5] 26.5 3.2 [þ3.2] 3.1 6.1 [1.6], 6.1 [0] 6.2, 6.1
mDMO (1000)
Male 35.1 [þ0.6] 34.9 4.0 [þ17.6] 3.4 7.6 [þ4.1], 7.7 [þ5.5] 7.3, 7.3 NTF
Female 27.8 [þ0.7] 27.6 3.3 [2.9] 3.4 6.7 [þ4.7], 7.0 [þ2.9] 6.4, 6.8
a Number in [] represents percent ± compared to control.
b No treatment-related ﬁndings; BW: body weight.
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related ﬁndings were noted at necropsy following treatment with
sDMO, cDMO or mDMO. The only ﬁndings noted at necropsy in the
three studies were periovarian cysts in females in the study where
mDMO was administered. These ﬁndings were not considered
treatment-related because they are common ﬁndings in CD-1 mice
and occurred at the same rate in the control (1 animal out of 10) and
test groups (1 animal out of 10). Thus, the No Observable Adverse
Effect Levels (NOAEL) for sDMO, cDMO and mDMO were the
highest dose levels administered in each case.
4. Discussion
DT soybean, cotton and maize were developed through consti-
tutive expression of DMO targeted into chloroplasts. The DMO
proteins expressed in these DT crops exhibit 91.6%e97.1% amino
acid sequence identity with the DMO cloned from S. maltophilia,
strain DI-6 that was found at the site of a dicamba manufacturing
plant (Krueger et al., 1989). The focus of the present study was to
assess if small amino acid sequence differences outside the active
site of DMO in these three DTcropswould raise any safety concerns.
Given the importance of functional characterization of intro-
duced proteins for protein safety assessment (Codex Alimentarius,
2009; Delaney et al., 2008; Hammond et al., 2013; Herouet et al.,
2005; Kier and Petrick, 2008), several functional and biochemical
properties of the various forms of DMO in these three DT crops
were evaluated. Because glycosylation can alter the physiochemical
properties of a protein (e.g., function, half-life), assessing whether
the plant-produced protein is glycosylated is one component of
protein safety assessment (Raybould et al., 2013; Wang et al., 2015).
Glycosylation assays showed that all forms of DMO, like the bac-
terial DMO on which they were based, were not glycosylated (data
not shown). This result is consistent with the fact that a search for
potential glycosylation sites of DMO found only a few possible O-
linked glycosylation sites and no likely N-linked glycosylation sites.
Another characteristic of the plant-produced DMO that was
assessed was whether the immunoreactive properties of plant-
produced DMO from DT cotton and DT maize were comparable to
their respective E. coli-produced DMO forms. Immunoreactive
analysis veriﬁes the protein intactness and distinguishes potential
differences in immunoreactive properties, which is an essential
component of biotech protein characterization (Raybould et al.,
2013). In both cases, immunoreactive properties were shown to
be similar. Similarly, the plant-produced sDMO were also immu-
noreactive to the polyclonal antibody raised against the E. coli-
produced wild type DMO protein and not glycosylated. Therefore,
these results support DT crop-produced DMO do not have othermodiﬁcation except small sequence differences illustrated in Fig 1B.
Crystal structure analysis of DMO indicates that the catalytic
domain of DMO contains no contribution from an N-terminal
extension region (D'Ordine et al., 2009; Dumitru et al., 2009). The
fact that all of the forms of DMO in these DT crops were active both
in vitro by enzymatic assay and in vivo by conferring dicamba
tolerance (Behrens et al., 2007; Cao et al., 2011), and yet some of
these DMO forms have varying degrees of an extended N-terminal
sequence from incomplete processing of the CTP, demonstrates that
thesemodiﬁcations at the N-terminus of DMO do not interferewith
its functional activity, as previously concluded (D'Ordine et al.,
2009; Dumitru et al., 2009; Herman et al., 2005). A W112C sub-
stitution in sDMO, structurally located outside the Rieske cluster
and catalytic domain (D'Ordine et al., 2009; Dumitru et al., 2009;
Herman et al., 2005), also does not interfere with its functional
activity. All residues involved in the coordination of the Rieske
cluster and catalytic domain (D'Ordine et al., 2009; Herman et al.,
2005) are completely conserved in all DMO forms in these three
DT crops (Fig. 1 B). In addition, the substrate speciﬁcity of DMO for
dicamba is due to the speciﬁc interactions between residues in the
active site and the chlorine atoms, carboxylate moiety and ring
structure of dicamba, which are primarily involved in orienting the
substrate in the catalytic pocket (D'Ordine et al., 2009; Dumitru
et al., 2009). Previously, DMO activity was tested by two indepen-
dent laboratories using O-anisic acid as a pseudo substrate, which is
structurally similar to dicamba except for the absence of chlorines
(D'Ordine et al., 2009; Dumitru et al., 2009). No signiﬁcant DMO
activity was detected with O-anisic acid under standard assay
conditions. 4-Hydroxy-3-methoxybenzoic acid (vanillic acid), also
structurally similar to dicamba but lacking the chlorine moieties,
was tested and similarly showed no DMO activity, supporting the
conclusion that the chlorine atoms of dicamba are required for the
proper positioning of the substrate for DMO catalytic activity. The
DMO crystal structure, combined with the functional and physi-
ochemical characterization presented in this study, conﬁrm that
the alternative processing of the N-terminal CTP, single amino acid
insertion at N-terminal and an amino acid substitution among
various forms of DMO do not result in alterations in the DMO
functional structure, substrate speciﬁcity, enzymatic mode of ac-
tion and phenotypic trait of dicamba tolerance (Behrens et al.,
2007; Cao et al., 2011; D'Ordine et al., 2009; Feng and Brinker,
2014). Therefore, the data generated on these various forms of
DMO proteins are representative of the DMO family.
For proteins, as is also true for much of biology, structure gov-
erns function (Hammond et al., 2013). Hence, bioinformatic anal-
ysis is a key dataset in the weight of evidence assessment of protein
safety since it will readily identify if an introduced protein is
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gens. The analysis presented in this study for the various forms of
DMO in these three DT crops demonstrated that no structurally
relevant similarity exists with any known toxic or allergenic pro-
teins that would be harmful to human or animal health. An absence
of homology between various forms of DMO and known allergens
and protein toxins supports the conclusion that there is no safety
concern with DMO expressed in these three DT crops and that the
sequence differences described have no impact on this conclusion.
While bioinformatic analysis determined that all forms of DMO
in these three DT crops are not structurally and functionally similar
to any toxins or allergens, it can also provide information about
whether proteins known to be safe in the diet have signiﬁcant
similarity with DMO. Because high sequence and/or structural
similarity often correlates with a conserved biological role
(Hammond et al., 2013), bioinformatic analysis to evaluate evolu-
tionary relationships of proteins are valuable in safety evaluations.
DMO belongs to the family of Rieske non-heme iron oxygenases
that perform an exocyclic monooxygenation. Rieske domain pro-
teins are ubiquitous in numerous bacterial and plant species; more
than 130 Rieske non-heme iron oxygenases have been reported
from different species (Chen et al., 2014). Structures for a number of
these proteins have been determined. As presented in this study, a
sequence and structure analysis of 18 representative proteins
revealed oxygenases with highly structural (domain/tertiary
structure) and functional (oxygenation) similarity to the DMO
protein are present in crops with a history of safe consumption,
such as sugar beet (Betula vulgaris), maize (Zea mays), tomato (So-
lanum lycopersicum) and rice (Oryza sativa) (Fig. 2). Therefore, DMO
proteins expressed in DT crops are structurally similar to Rieske
oxygenases present in the human diet and directly consumed in
common foods, including tomato which is frequently eaten raw,
supporting a conclusion that DMO has a comparable history of safe
use. It should be noted that the various N-terminal sequence ex-
tensions do not have additional safety concerns because Rubisco
protein and CTPs in the three DT crops are natively expressed in
plants with a history of safe use (Hammond et al., 2013).
Evolutionary changes within protein families used as food pro-
cessing enzymes have not resulted in the enzymes becoming toxic
to humans (Pariza and Cook, 2010). Similarly, it is highly unlikely
that genetic modiﬁcation of a protein will turn a nontoxic protein
into a toxic protein because any sequence changes would need to be
consistent with a biological mechanism of toxicity (Hammond
et al., 2013). Analysis of the source organism from which DMO
was cloned is also part of theweight of evidence approach for safety
assessment. It was reported over forty years ago thatmicrobeswere
able to convert dicamba to 3,6-dichlorosalicylic acid (Smith, 1974).
Krueger et al. (1989) established that dicamba can be degraded by
pure cultures of bacteria under aerobic conditions. They isolated
eight species of bacteria from soil and water samples with long
histories of dicamba exposure that were capable of using dicamba
as the sole carbon source. The dmo gene is derived from the bac-
terium S. maltophilia (Herman et al., 2005), which is an aerobic,
ubiquitous environmental gram negative bacterium commonly
found in aquatic environments, soil, and plants. The dmo gene is
present on a megaplasmid in cells of S. maltophilia (Herman et al.,
2005). Recently, homologous DMO proteins with 97e99% amino
acid sequence identity to the wild type DMO were also identiﬁed
from Sphingobium fuliginis (accession number: AJS1906.1) and
Sphingomonas sp. Y57 (accession number: WP_047168602.1) bac-
teria species, indicating that many soil bacteria are capable of
degrading dicamba through the DMO activity. S. maltophilia can be
found in a variety of foods and feeds (Echemendia, 2010; Qureshi
et al., 2005), and is widespread in the home environment
(Denton and Kerr, 1998; Denton et al., 1998; Ryan et al., 2009).S. maltophiliawas also detected in raw and pasteurized milks (Juffs,
1973). Infections caused by S. maltophilia are extremely uncommon
(Cunha, 2009). Additionally, S. maltophilia has not been reported to
be a source of allergens (FARRP, 2016). The ubiquitous presence of
S. maltophilia in the environment and the incidental contamination
of foods without any adverse safety reports support a conclusion
that the source organism for the dmo gene is not associated with
any toxic or allergenic biological processes.
While functional characterization, bioinformatics and history of
safe use analyses show that the consumption of the various forms
of DMO from these three DT crops is safe, additional safety studies
were also conducted. Most dietary proteins are digested to con-
stituent amino acids and small peptides in the mammalian
gastrointestinal system and absorbed for nutritive purposes.
Although the correlation between allergenicity and pepsin resis-
tance is imperfect (Herman et al., 2006), some proteins that are
food allergens are relatively resistant to pepsin digestion (Asero
et al., 2000; Astwood et al., 1996; Yagami et al., 2000). In addi-
tion, rapid degradation by pepsin provides evidence that exposure
to the introduced proteinwill beminimized following consumption
(Hammond et al., 2013; Kier and Petrick, 2008). Test results show
that all forms of DMO from these three DT crops were completely
digested within the ﬁrst measured time point by pepsin and,
similarly in a separate assay by pancreatin, supporting a conclusion
that exposure to any form of structurally and functionally intact
DMO is unlikely. All forms of DMO also showed complete loss of
functional activity by heating at temperatures 55 C and above.
Given virtually all consumed foods from soybeans and maize are
exposed to heating during processing or cooking (Hammond and
Jez, 2011), the heat labile property of DMO is consistent with the
conclusion that dietary exposure to functionally intact DMO is
unlikely.
Although bioinformatic and history of safe use assessments
identiﬁed no hazards with respect to a potential for toxicity, acute
toxicity studies were conducted with the various DMO proteins. An
acute toxicity study is a supplemental method to assess if a protein
is toxic because most known protein toxins exert toxicity through
acute mechanisms (Pariza and Johnson, 2001; Sjoblad et al., 1992).
The forms of DMO introduced into soybean, cotton and maize were
orally administered to mice independently. These three indepen-
dent toxicity studies together included a total of 50 mice (25 males
and 25 females), with doses of up to 1000mg DMO/kg bodyweight,
and no adverse effects were observed on the three studies.
To put the maize DMO acute toxicity study dose level into
context, consider the following extreme example: if 100% of all
cultivated maize used for food production had the DT trait (with an
average expression level of 0.19 mg DMO protein/g maize grain), a
60 kg human would have to eat approximately 3.2  105 kg
(704,000 pounds) of DT maize in a single day to achieve a DMO
intake level similar to the NOAEL of the acute toxicity study with
mDMO (1000 mg/kg).
In the acute toxicity study with sDMO, the plant-produced DMO
was used because it consists of a mixture of two forms of the DMO
protein. Therefore, the plant-derived DMO retains the natural ratio
and active trimeric form expected to be present in DT-soybean.
sDMO is expressed at a relatively low level in seed tissue that
contains high levels of oils and carbohydrates, which complicate
protein puriﬁcation in general and limited the ability to produce
large amounts of the DMO protein. Considering the challenges
associated with the isolation and puriﬁcation of DMO from soybean
grain, a margin of exposure-based dosing strategy for the
mammalian toxicity study was used. This is a toxicologically sound
approach because dose levels that provide a large safety factor (i.e.,
Margin of Exposure 100) are typically considered an appropriate
demonstration of a substance's safety (Faustman and Omenn,
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previous paragraph, the sDMO dose level (140 mg/kg) may appear
moderate. However, it is worth noting that other substances
routinely ingested by humans are lethal at lower dose levels (e.g.,
caffeine has an oral LD50 of <140 mg/kg in mice) (Windholz, 1983).
The signiﬁcance of a 140 mg/kg NOAEL can also be demonstrated
re-applying the grain consumption scenario from the preceding
paragraph with soybean in place of maize. A 60 kg human would
have to eat more than three times their body weight (approxi-
mately 195 kg) of DT soybean (with an average expression level of
43 mg DMO protein/g soybean seed) in a single day to achieve an
sDMO intake level similar to the NOAEL of the acute toxicity study
with sDMO (140 mg/kg). This theoretical soybean consumption
scenario dwarfs actual soybean consumption rates, even in world
areas with high levels of soybean consumption. For example, the
WHO GEMS program indicates Japanese children ages 6 years and
under have a soybean consumption value of 5.55 g/kg/day (the
highest 97.5th percentile “Eater-Only” worldwide). In the theoret-
ical scenario above, the personwould have a soybean consumption
value of 3250 g/kg/day (195 kg soybean by a 60 kg human).
Dietary exposure to DMO from DT cotton is negligible because
the processed fractions of cotton consumed by humans (reﬁned,
bleached and deodorized oil and linters) contain negligible
amounts of protein (Reeves and Weihrauch, 1979). In spite of this
fact, an acute mouse study was conducted to comply with global
requirements that do not entirely consider these differences in
cotton. In that case a dose level of 283 mg/kg was used and no
adverse health effects were observed. Therefore, the apparent
absence of hazard and lack of exposure result in negligible risk.
Furthermore, these are very conservative estimates of human
exposure to DMO because it assumes no loss of the DMO protein
during storage, processing and/or cooking of the grain or food or
during digestion. As described above, all forms of DMO from three
DT crops were shown to be heat labile and readily susceptible to
proteolytic degradation, therefore resulting in no meaningful di-
etary exposure to intact DMO from any of these DT crops.
As presented in this report, the three forms of DMO introduced
in DT crops (soy, cotton, maize): (1) is sourced from bacteria that
have no association with allergenicity; (2) are related to proteins
that have a history of safe use; (3) are not structurally or func-
tionally related to known toxins or allergens; (4) have a substrate-
speciﬁc activity that confers tolerance to dicamba in crops; (5) are
readily cleaved by mammalian digestive enzymes; and (6) are heat
labile. Furthermore, acute toxicity studies with each of these three
forms of DMO demonstrated no adverse effects following treat-
ment. Thus, these weights of evidence align well with conclusions
that the various forms of DMO in these three DTcrops, while having
small amino acid sequence differences have similar structure,
function and safety properties and that there is no risk for humans
to consume foods containing DMO.
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